Advisor Group Holdings »

C4 Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0k 530 5.70
2023-09-30 $1.9k 1.0k 1.86
2022-12-31 $0 185 0.00

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
BlackRock
OrbiMed Advisors
Soleus Capital Management
Vanguard Group
Commodore Capital
State Street Corporation
Bank of America Corporation
Balyasny Asset Management
Silverarc Capital Management
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics